SCHEMBL2556954

SCHEMBL2556954

CC(=O)CCc1ccc(OCCCC(=O)O)cc1

nearest known ligand 0.67

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.67
LMNA P02545 1/20 0.67
FFAR1 O14842 6/20 0.65
PPARG P37231 3/20 0.56
PPARD Q03181 1/20 0.56
PPARA Q07869 1/20 0.56
ALDH1A1 P00352 2/20 0.55
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
FFAR4 Q5NUL3 1/20 0.54
S1PR1 P21453 1/20 0.52
S1PR3 Q99500 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2561156 0.95 FFAR1 (0.66) L3MBTL1LMNAFFAR1PPARGPPARD
SCHEMBL1809723 0.92 L3MBTL1 (0.69) L3MBTL1LMNAFFAR1PPARGPPARD
SCHEMBL26455103 0.87 LMNA (0.66) L3MBTL1LMNAFFAR1ALDH1A1MEN1
SCHEMBL20382460 0.86 FFAR1 (0.63) L3MBTL1LMNAFFAR1PPARGPPARD
SCHEMBL9733807 0.84 LMNA (0.62) L3MBTL1LMNAFFAR1ALDH1A1S1PR1
SCHEMBL2559840 0.83 LMNA (0.57) L3MBTL1LMNAFFAR1PPARDPPARA
SCHEMBL14951699 0.83 L3MBTL1 (0.76) L3MBTL1LMNAFFAR1ALDH1A1MEN1
SCHEMBL10937896 0.83 LMNA (0.57) L3MBTL1LMNAFFAR1ALDH1A1MEN1
SCHEMBL1205783 0.83 LMNA (0.87) L3MBTL1LMNAFFAR1PPARGPPARD
SCHEMBL16686916 0.83 LMNA (0.69) L3MBTL1LMNAFFAR1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11225655-B2 Bi-functional complexes and methods for making and using such complexes NUEVOLUTION A/S (DK) 2022-01-18 US disclosed
EP-3540059-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2019-09-18 EP disclosed
EP-2558577-B1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION AS (DK) 2018-12-12 EP disclosed
US-20130281324-A1 BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2013-10-24 US disclosed
EP-2558577-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2013-02-20 EP disclosed
WO-2012135034-A9 FIBER WITH MICROBIAL REMOVAL, MICRO-BIOCIDAL, OR STATIC GROWTH CAPABILITY RECEPTORS LLC (US) 2012-12-27 WO disclosed
WO-2012135034-A1 FIBER WITH MICROBIAL REMOVAL, MICRO-BIOCIDAL, OR STATIC GROWTH CAPABILITY RECEPTORS LLC (US) 2012-10-04 WO disclosed
WO-2011127933-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2011-10-20 WO disclosed
EP-0689845-B1 Conjugates of methyltrithio antitumor agents and intermediates for their synthesis AMERICAN CYANAMID CO (US) 2002-09-04 EP disclosed
US-5877296-A REACTING DISULFIDE ANALOGS OF CALICHEAMICIN FAMILY WITH A CARRIER SUCH AS PROTEIN, PEPTIDE, MONO AND POLYCLONAL ANTIBODIES, THEIR ANTIGEN-RECOGNIZING FRAGMENTS AND CHEMICALLY OR GENETICALLY ENGINEERED COUNTERPARTS AMERICAN CYANAMID COMPANY (US) 1999-03-02 US disclosed
US-5773001-A ANTIGROWTH AGENTS AMERICAN CYANAMID COMPANY (US) 1998-06-30 US disclosed
US-5767285-A USEFUL FOR CONSTRUCTING DRUG CONJUGATES; ANTIBIOTIC ANTITUMOR AGENTS AMERICAN CYANAMID COMPANY (US) 1998-06-16 US disclosed
US-5739116-A DISULFIDE DERIVATIVE OF CALICHEAMICIN FAMILY; ANTITUMOR ANTIBIOTICS AMERICAN CYANAMID COMPANY (US) 1998-04-14 US disclosed
EP-0689845-A2 Conjugates of methyltrithio antitumor agents and intermediates for their synthesis AMERICAN CYANAMID COMPANY (US) 1996-01-03 EP disclosed